Figure 13.
A new concept of the evolution of the breast cancer cell populations under the increasing selecting pressures of antiestrogenic environments to become vulnerable populations that are killed by estrogen when therapy stops (adapted from Jordan, 2014, JNCI, epub ahead of print).